Recurrent cardiocirculatory arrest after kidney transplantation related to intravenous methylprednisolone bolus therapy.
Intravenous bolus therapy with steroids is often used in standard immunosuppression initially after organ transplantation and to treat acute graft rejection. Although this regimen in generally is safe, severe adverse effects can occur. This letter gives a picture of the eventful clinical course of a patient with preexisting heard problems after renal transplantation. This case report proves lethal cardiopulmonary complications closely related to the recurrent intravenous administration of methylprednisolone in a risk patient. Severe side effects after the application of high-dose steroids are possible. If risk patients are identified, steroid bolus therapy should be avoided or, if not possible, should only be done under close monitoring.